STAAR Surgical Co
STAA18.035USD
+0.275+1.55%
交易中 （美東）報價延遲15分鐘
893.15M總市值
虧損本益比TTM
關於 STAAR Surgical Co 公司
STAAR Surgical Company 設計、開發、製造和銷售用於眼部植入的晶狀體以及用於將晶狀體送入眼部的附件輸送系統。這些晶狀體爲患者提供了視覺自由，減少或消除了對眼鏡或隱形眼鏡的依賴。該公司是全球矯正或屈光手術中使用的晶狀體制造商。其產品銷往約 75 個國家/地區，在日本、德國、西班牙、美國、加拿大、英國和新加坡設有直銷渠道，在中國、韓國、印度、法國、比荷盧三國和意大利設有直銷和獨立分銷渠道。該公司以其 EVO 系列晶狀體營銷和銷售用於屈光手術以治療近視的 ICL。該公司的 EVO 系列晶狀體包括 EVO ICL、EVO+ ICL 和 EVO Visian ICL。該公司還營銷和銷售用於治療遠視的 ICL 晶狀體，稱爲 Visian ICL。
公司簡介
公司代碼STAA
公司名稱STAAR Surgical Co
上市日期Feb 24, 1992
CEOMr. Stephen C. (Steve) Farrell, CPA
員工數量1157
證券類型Ordinary Share
年結日Feb 24
公司地址1911 Walker Ave
城市MONROVIA
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編91016
電話16263037902
網址https://www.staar.com/
公司代碼STAA
上市日期Feb 24, 1992
CEOMr. Stephen C. (Steve) Farrell, CPA
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
+54.07%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
-57.51%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
-14.65%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
4.60K
+27.61%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
Mr. Arthur Crosswell Butcher
Mr. Arthur Crosswell Butcher
Independent Director
Independent Director
--
--
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
+54.07%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
-57.51%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
-14.65%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
4.60K
+27.61%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
ICLs
41.50M
97.44%
Other surgical products
1.09M
2.56%
地區USD
名稱
營收
佔比
Others
18.02M
42.30%
Japan
11.39M
26.75%
South Korea
7.33M
17.22%
U. S.
5.46M
12.82%
China
389.00K
0.91%
業務
地區
業務USD
名稱
營收
佔比
ICLs
41.50M
97.44%
Other surgical products
1.09M
2.56%
股東統計
更新時間: 6月15日 週日
更新時間: 6月15日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Broadwood Capital, Inc.
27.35%
BlackRock Institutional Trust Company, N.A.
14.16%
The Vanguard Group, Inc.
8.87%
Armistice Capital LLC
6.06%
Soleus Capital Management, L.P.
5.17%
Other
38.39%
持股股東
持股股東
佔比
Broadwood Capital, Inc.
27.35%
BlackRock Institutional Trust Company, N.A.
14.16%
The Vanguard Group, Inc.
8.87%
Armistice Capital LLC
6.06%
Soleus Capital Management, L.P.
5.17%
Other
38.39%
股東類型
持股股東
佔比
Hedge Fund
45.54%
Investment Advisor
39.69%
Investment Advisor/Hedge Fund
15.50%
Research Firm
4.34%
Pension Fund
1.05%
Sovereign Wealth Fund
0.92%
Individual Investor
0.51%
Bank and Trust
0.35%
Venture Capital
0.06%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
542
53.50M
108.02%
-4.10M
2025Q1
586
53.67M
108.47%
-5.73M
2024Q4
611
49.68M
100.75%
-8.34M
2024Q3
633
50.35M
102.36%
-6.37M
2024Q2
636
49.69M
101.15%
-10.70M
2024Q1
632
50.54M
103.45%
-9.24M
2023Q4
640
52.70M
107.96%
-9.84M
2023Q3
658
55.47M
114.38%
-3.16M
2023Q2
667
52.64M
108.92%
-2.50M
2023Q1
670
50.91M
105.54%
-1.16M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Broadwood Capital, Inc.
13.55M
27.35%
+1.09M
+8.75%
Apr 22, 2025
BlackRock Institutional Trust Company, N.A.
7.01M
14.16%
-305.44K
-4.17%
Mar 31, 2025
The Vanguard Group, Inc.
5.41M
10.92%
-439.86K
-7.52%
Mar 31, 2025
Armistice Capital LLC
3.00M
6.06%
+2.13M
+244.04%
Mar 31, 2025
Soleus Capital Management, L.P.
2.56M
5.17%
+2.56M
--
Mar 31, 2025
Resona Asset Management Co., Ltd.
2.17M
4.38%
+669.43K
+44.62%
Mar 31, 2025
State Street Global Advisors (US)
1.99M
4.03%
-57.87K
-2.82%
Mar 31, 2025
Yunqi Capital Limited
1.94M
3.91%
+1.17M
+152.48%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.19M
2.4%
+14.77K
+1.26%
Mar 31, 2025
American Capital Management, Inc.
1.01M
2.04%
+161.75K
+19.06%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
SPDR S&P Health Care Equipment ETF
1.75%
ROBO Global Healthcare Technology & Innovation ETF
1.63%
Invesco S&P SmallCap Health Care ETF
0.59%
Royce Quant Small-Cap Quality Value ETF
0.2%
WisdomTree US SmallCap Quality Growth Fund
0.14%
Principal U.S. Small-Cap ETF
0.1%
SPDR S&P SmallCap 600 ESG ETF
0.09%
SPDR S&P 600 Small Cap Growth ETF
0.07%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.07%
iShares ESG Select Screened S&P Small-Cap ETF
0.07%
查看更多
SPDR S&P Health Care Equipment ETF
佔比1.75%
ROBO Global Healthcare Technology & Innovation ETF
佔比1.63%
Invesco S&P SmallCap Health Care ETF
佔比0.59%
Royce Quant Small-Cap Quality Value ETF
佔比0.2%
WisdomTree US SmallCap Quality Growth Fund
佔比0.14%
Principal U.S. Small-Cap ETF
佔比0.1%
SPDR S&P SmallCap 600 ESG ETF
佔比0.09%
SPDR S&P 600 Small Cap Growth ETF
佔比0.07%
Vanguard S&P Small-Cap 600 Growth Index Fund
佔比0.07%
iShares ESG Select Screened S&P Small-Cap ETF
佔比0.07%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
